In vivo characterization and quantification of neurofibrillary tau PET radioligand [18F]MK-6240 in humans from Alzheimer’s disease dementia to young controls

Christian, PhD, B. T., and S. C. Johnson, PhD. In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand [18F]MK-6240 in Humans from Alzheimer’S Disease Dementia to Young Controls.

Betthauser TJ, Cody KA, Zammit MD, Murali D, Converse AK, Barnhart TE, Stone CK, Rowley HA, Johnson SC, Christian BT. (2019). In vivo characterization and quantification of neurofibrillary tau PET radioligand [18F]MK-6240 in humans from Alzheimer’s disease dementia to young controls. Journal of Nuclear Medicine, 60(1):93-99. doi: 10.2967/jnumed.118.209650.